ResearcherSeoul National UniversityNo recent work listed

Mei Hua Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6933-5843; OpenAlex author ID A5024749992. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 2 papers

Papers 2

The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy. Co-author DOI 10.1002/cam4.2677 ↗
Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer. Co-author DOI 10.4143/crt.2019.183 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Do‐Youn Oh · 2 shared papers, 2020 · strength 0.26
- Paper Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer. DOI 10.4143/crt.2019.183 ↗
- Paper The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy. DOI 10.1002/cam4.2677 ↗
Yung‐Jue Bang · 2 shared papers, 2020 · strength 0.26
- Paper Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer. DOI 10.4143/crt.2019.183 ↗
- Paper The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy. DOI 10.1002/cam4.2677 ↗
Hyunkyung Park · 1 shared paper, 2020 · strength 0.13
- Paper The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy. DOI 10.1002/cam4.2677 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.